Department of Pathology
Johns Hopkins Medicine
The mission of the Department of Pathology is to discover, disseminate and apply knowledge in the study of disease, to advance the field of human health, and to provide the highest quality of patient care.
Department of Pathology
Johns Hopkins Medicine
The mission of the Department of Pathology is to discover, disseminate and apply knowledge in the study of disease, to advance the field of human health, and to provide the highest quality of patient care.
Department of Pathology
Johns Hopkins Medicine
The mission of the Department of Pathology is to discover, disseminate and apply knowledge in the study of disease, to advance the field of human health, and to provide the highest quality of patient care.
For Patients
Do you need a second opinion on your pathology diagnosis? Our expert pathologists can help assure you have the most accurate diagnosis.
Second Opinions
For Clinicians
The Johns Hopkins Medical Laboratory provides world-recognized expertise in Surgical Pathology and Cytopathology consultation.
Consultation ServicesLatest News
Hopkins Residency Training Program Ranks #1 - Jul 17, 2025
Congratulations, Dr. J. Brooks Jackson! - Jun 2, 2025
Congratulations, Drs. Tait Huso and Jae Lee! - May 29, 2025
Read AllRecent Publications
Our department's impact on pathology research is evident: Johns Hopkins Pathology has been the #1 NIH-funded pathology department for 15 of the past 17 years. Below are recent highlighted publications from our department.
The Next Frontier: Engineering Cell Immunotherapies
Livingston NK, ...,, Spangler JB, Mao HQ, Schneck JP. In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node Matrix. Adv Mater. 2024 Jun;36(23):e2310043. doi: 10.1002/adma.202310043. Epub 2024 Mar 1. PMID: 38358310.
Read full article
The Next Frontier: Engineering Cell Immunotherapies
Faculty Bio
Livingston NK, ...,, Spangler JB, Mao HQ, Schneck JP. In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node Matrix. Adv Mater. 2024 Jun;36(23):e2310043. doi: 10.1002/adma.202310043. Epub 2024 Mar 1. PMID: 38358310.
Breakthrough in Cancer Vaccines: Shifting to Nucleic Acid-based Platforms
Chi WY, ..., Huang YM, Wu AA, Hung CF, Wu TC. Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens. J Biomed Sci. 2024 Oct 9;31(1):94. doi: 10.1186/s12929-024-01082-x. PMID: 39379923.
Read full article
Breakthrough in Cancer Vaccines: Shifting to Nucleic Acid-based Platforms
Faculty Bio
Chi WY, ..., Huang YM, Wu AA, Hung CF, Wu TC. Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens. J Biomed Sci. 2024 Oct 9;31(1):94. doi: 10.1186/s12929-024-01082-x. PMID: 39379923.
A Closer Look: Speedy EM Processing Enhances Diagnostic Assessment of Renal Biopsies
Pinedo A, ..., Arend LJ, Dai DF. Fast Processing of Electron Microscopic Specimen Preserved Ultrastructure of Glomeruli and Electron-Dense Deposits in Diagnostic Renal Biopsies. Mod Pathol. 2025 Feb;38(2):100662. Epub 2024 Nov 20. PMID: 39577665.
Read full article
A Closer Look: Speedy EM Processing Enhances Diagnostic Assessment of Renal Biopsies
Faculty Bio
Pinedo A, ..., Arend LJ, Dai DF. Fast Processing of Electron Microscopic Specimen Preserved Ultrastructure of Glomeruli and Electron-Dense Deposits in Diagnostic Renal Biopsies. Mod Pathol. 2025 Feb;38(2):100662. Epub 2024 Nov 20. PMID: 39577665.
Spotlighting Glioblastoma: Tracking Molecular Evolution and Treatment Outcome
Lucas CG, ..., Solomon DA. Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12;27(1):89-105.PMID: 39560080
Read full article
Spotlighting Glioblastoma: Tracking Molecular Evolution and Treatment Outcome
Faculty Bio
Lucas CG, ..., Solomon DA. Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12;27(1):89-105.PMID: 39560080
Grand Rounds
Each Monday at 8:30 am, the Department of Pathology hosts a series of speakers to discuss advancements in the field of disease diagnosis and treatment.
Next Session
-
View session details